POC CLINITEST Rapid COVID-19 InfluenzaAntigen Test Box with Cassette

CLINITEST COVID-19 + Influenza Antigen Test

One swab, three results–know with confidence.

When your patients present with a fever, cough, and other common respiratory symptoms, choosing the appropriate treatment requires determining the cause of their illness. The CLINITEST® Rapid COVID-19 + Influenza Antigen Test, distributed by Siemens Healthineers, enables you to detect and differentiate infections involving any combination of these three respiratory viruses at the point of care.

CLINITEST Rapid COVID-19 Antigen Test

Convenient 3-in-1 test

Test patients for SARS-CoV-2, flu A, and flu B infection with a single sample.

CLINITEST Rapid COVID-19 Antigen Test target

High sensitivity/specificity vs. PCR

SARS-CoV-2: 98.32%/99.60%
Flu A: 88.57%/97.78%
Flu B: 87.10%/97.87%

CLINITEST Rapid COVID-19 Antigen Test swab cassette

Flexible for patients and providers

Nasopharyngeal swab administered by healthcare professionals in virtually any setting, with no instrumentation or equipment required.

CLINITEST Rapid COVID-19 Antigen Test Community

Helps to Reduce Community Spread

Results can facilitate prompt self-isolation of infected patients, if deemed necessary, to prevent the spread of COVID-19 and influenza. 






98.32% (117/120)

95% CI: 94.06–99.80% 

99.60% (743/745)

95% CI: 98.83–99.92% 

99.42% (860/865)

95% CI: (98.66–99.81%) 

Influenza A

88.57% (31/35) 

95% CI: 73.26–96.80% 

97.78% (88/90) 

95% CI: 92.20–99.73% 

95.20% (119/125)

95% CI: 89.85–98.22% 

Influenza B

87.10% (27/31)

95% CI: 70.17–96.37%

97.87% (92/94)

95% CI: 92.52–99.74%

95.20% (119/125)

95% CI: 89.85–98.22%

COVID-19 illustration

What is antigen testing?

  • Detects the presence of a specific viral antigen, most commonly the nucleocapsid protein
  • Typical sample types: nasopharyngeal, anterior nasal, and oropharyngeal swabs
  • Results are dependent on viral load and may not correlate with alternative technologies such as cell culture or NAAT/RT-PCR results. 1
Flu illustration
COVID-19 Use Case

Omicron Update
Siemens Healthineers is committed to monitoring all current and emerging variants of concern (VOCs) by directly testing with clinical samples and using a computer-based inspection tool called in silico analysis. The Omicron variant (B.1.1.529) is recognized by the WHO, CDC, and ECDC as a VOC. Siemens Healthineers internal data demonstrate that the CLINITEST® Rapid COVID-19 Antigen (Self) Test detects SARS-CoV-2 virus/coronavirus infection of the Omicron variant and its major sub-variants, including BA.1, BA.2, BA.2.75, BA.3, BA.4, BA.4.6, BA.5, BF.7, and XE.

Subscription Button Icon

Keep up to date on the latest trends in healthcare. Read about current developments, new products and upcoming events.